FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pharmacology, microbiology and biotechnology, and aims at increasing Doximag's biocidal and therapeutic effect. To increase Doximag's biocidal and therapeutic effect, dissolved in 1 liter of distilled or boiled tap water with 50 g of Doximag, 0.1 % of glutaric aldehyde, 1–2 % of aethonium and 3–5 mg of silver ions. Obtained solution is packaged into flasks with capacity of 100 ml and more, closed with rubber plugs, rolled with aluminum caps and labeled.
EFFECT: use of the invention enables to reduce content with simultaneous increase in the biocidal and therapeutic action of Doximag.
1 cl, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INCREASING BIOCIDAL AND THERAPEUTIC ACTION OF SUSPENSION-CREAM WITH ENROFLOXACIN | 2012 |
|
RU2491922C1 |
METHOD FOR INCREASING BIOCIDAL AND THERAPEUTIC ACTION OF SUSPENSION-CREAM WITH LINCO-SPECTIN | 2012 |
|
RU2505285C1 |
METHOD FOR INCREASING BIOCIDAL AND THERAPEUTIC EFFICACY OF STAPHYLOCOCCAL ANATOXIN VACCINE | 2014 |
|
RU2562585C1 |
METHOD FOR INCREASING BIOCIDAL AND THERAPEUTIC ACTION OF SUSPENSION-CREAM WITH METRONIDAZOLE | 2012 |
|
RU2527330C2 |
METHOD OF INCREASING LEVOMYCETINUM (CHLORAMPHENICOL) EFFICIENCY | 2014 |
|
RU2571558C2 |
METHOD OF PRODUCING BIOCIDE AGENT IN THE FORM OF FURACILIN SOLUTION | 2015 |
|
RU2600036C1 |
METHOD OF PRODUCING AND USING SOLUTION AND LINIMENT OF FURAZOLIDONE | 2018 |
|
RU2690493C1 |
METHOD FOR ENHANCEMENT OF EFFICACY OF E.coli RESISTANT ANTIBIOTICS | 2011 |
|
RU2476210C1 |
METHOD FOR INCREASING BACTERICIDAL ACTIVITY AND PROVIDING VIRUSOCIDAL AND FUNGICIDAL ACTION ON ANTIBIOTICS | 2011 |
|
RU2477124C2 |
METHOD OF OBTAINING STAPHYLOCOCCAL ANATOXIN-VACCINE | 2011 |
|
RU2468078C1 |
Authors
Dates
2019-06-04—Published
2018-04-23—Filed